DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid - PubMed (original) (raw)
Comparative Study
DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid
S Burkhardt et al. Int J Biochem Cell Biol. 2001 Aug.
Abstract
Chromium (Cr) compounds are widely used industrial chemicals and well known carcinogens. Cr(III) was earlier found to induce oxidative damage as documented by examining the levels of 8-hydroxydeoxyguanosine (8-OH-dG), an index for DNA damage, in isolated calf thymus DNA incubated with CrCl(3) and H(2)O(2). In the present in vitro study, we compared the ability of the free radical scavengers melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK), resveratrol and uric acid to reduce DNA damage induced by Cr(III). Each of these scavengers markedly reduced the DNA damage in a concentration-dependent manner. The concentrations that reduced 8-OH-dG formation by 50% (IC(50)) were 0.10 microM for both resveratrol and melatonin, and 0.27 microM for AFMK. However, the efficacy of the fourth endogenous antioxidant, i.e. uric acid, in terms of its inhibition of DNA damage in the same in vitro system was about 60--150 times less effective than the other scavengers; the IC(50) for uric acid was 15.24 microM. These findings suggest that three of the four antioxidants tested in these studies may have utility in protecting against the environmental pollutant Cr and that the protective effects of these free radical scavengers against Cr(III)-induced carcinogenesis may relate to their direct hydroxyl radical scavenging ability. In the present study, the formation of 8-OH-dG was likely due to a Cr(III)-mediated Fenton-type reaction that generates hydroxyl radicals, which in turn damage DNA. Once formed, 8-OH-dG can mutate eventually leading to cancer; thus the implication is that these antioxidants may reduce the incidence of Cr-related cancers.
Similar articles
- Chromium(III)-induced 8-hydroxydeoxyguanosine in DNA and its reduction by antioxidants: comparative effects of melatonin, ascorbate, and vitamin E.
Qi W, Reiter RJ, Tan DX, Garcia JJ, Manchester LC, Karbownik M, Calvo JR. Qi W, et al. Environ Health Perspect. 2000 May;108(5):399-402. doi: 10.1289/ehp.00108399. Environ Health Perspect. 2000. PMID: 10811565 Free PMC article. - Increased levels of oxidatively damaged DNA induced by chromium(III) and H2O2: protection by melatonin and related molecules.
Qi W, Reiter RJ, Tan DX, Manchester LC, Siu AW, Garcia JJ. Qi W, et al. J Pineal Res. 2000 Aug;29(1):54-61. doi: 10.1034/j.1600-079x.2000.290108.x. J Pineal Res. 2000. PMID: 10949541 - Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions.
López-Burillo S, Tan DX, Mayo JC, Sainz RM, Manchester LC, Reiter RJ. López-Burillo S, et al. J Pineal Res. 2003 May;34(4):269-77. doi: 10.1034/j.1600-079x.2003.00041.x. J Pineal Res. 2003. PMID: 12662349 - On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.
Galano A, Tan DX, Reiter RJ. Galano A, et al. J Pineal Res. 2013 Apr;54(3):245-57. doi: 10.1111/jpi.12010. Epub 2012 Sep 23. J Pineal Res. 2013. PMID: 22998574 Review. - The antioxidative property of melatonin against brain ischemia.
Paterniti I, Cordaro M, Esposito E, Cuzzocrea S. Paterniti I, et al. Expert Rev Neurother. 2016 Jul;16(7):841-8. doi: 10.1080/14737175.2016.1182020. Epub 2016 May 9. Expert Rev Neurother. 2016. PMID: 27108742 Review.
Cited by
- Therapeutic potential of melatonin and its derivatives in aging and neurodegenerative diseases.
Verma AK, Singh S, Rizvi SI. Verma AK, et al. Biogerontology. 2023 Apr;24(2):183-206. doi: 10.1007/s10522-022-10006-x. Epub 2022 Dec 22. Biogerontology. 2023. PMID: 36550377 Review. - Protective Effect of Resveratrol against Hexavalent Chromium-Induced Genotoxic Damage in Hsd:ICR Male Mice.
Nicolás-Méndez T, Kacew S, Ortiz-Muñiz AR, Mendoza-Núñez VM, García-Rodríguez MDC. Nicolás-Méndez T, et al. Molecules. 2022 Jun 23;27(13):4028. doi: 10.3390/molecules27134028. Molecules. 2022. PMID: 35807276 Free PMC article. - Melatonin and the Brain-Heart Crosstalk in Neurocritically Ill Patients-From Molecular Action to Clinical Practice.
Bekała A, Płotek W, Siwicka-Gieroba D, Sołek-Pastuszka J, Bohatyrewicz R, Biernawska J, Kotfis K, Bielacz M, Jaroszyński A, Dabrowski W. Bekała A, et al. Int J Mol Sci. 2022 Jun 25;23(13):7094. doi: 10.3390/ijms23137094. Int J Mol Sci. 2022. PMID: 35806098 Free PMC article. Review. - Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders.
Galano A, Guzmán-López EG, Reiter RJ. Galano A, et al. Int J Mol Sci. 2021 Oct 27;22(21):11584. doi: 10.3390/ijms222111584. Int J Mol Sci. 2021. PMID: 34769013 Free PMC article. Review. - Melatonin, Its Metabolites and Their Interference with Reactive Nitrogen Compounds.
Hardeland R. Hardeland R. Molecules. 2021 Jul 5;26(13):4105. doi: 10.3390/molecules26134105. Molecules. 2021. PMID: 34279445 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical